For how long is a draining seton (drainage catheter) typically left in place for a patient with a fistula-in-ano (anal fistula)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Draining Seton Placement for Fistula-in-Ano

For cryptoglandular (non-Crohn's) fistula-in-ano, remove the draining seton between 6 weeks to 3 months after insertion, with most surgeons favoring removal around 6-12 weeks once drainage has resolved and inflammation has subsided. 1

Timing Based on Fistula Etiology

Cryptoglandular (Non-Crohn's) Fistulas

  • The optimal removal window is 6 weeks to 3 months post-insertion, as practiced by 58% of Dutch gastrointestinal surgeons surveyed in a national practice patterns study 1

  • Healing typically occurs within a median of 9 weeks (range 4-62 weeks) when setons are used as definitive treatment, with complete healing achieved in 78% of patients 2

  • For deep horseshoe fistulas specifically, setons can be removed as early as 21-32 days when combined with patient-performed irrigation techniques, compared to conventional loose seton treatment requiring longer duration 3

  • Setons can be left in place indefinitely if needed, though patients may prefer suppressive medical therapy over long-term seton placement 4

Crohn's Disease-Associated Fistulas

  • Remove the seton only after completing the induction phase of anti-TNF therapy (approximately 4-6 weeks) AND achieving resolution of proctitis 5

  • The timing of seton removal in Crohn's disease is highly variable across studies, ranging from 4 to 27 weeks post-insertion, reflecting the heterogeneity and low quality of available evidence 6

  • In the ACCENT 2 trial, all setons were removed by Week 2 of anti-TNF therapy, resulting in a 15% new abscess rate, suggesting this may be too early 5

  • When combining seton placement with anti-TNF therapy followed by surgical closure within 52 weeks, this approach achieves the best long-term outcomes, with cumulative fistula closure rates of 43.8% at 1 year, 82.2% at 3 years, and 93.7% at 5 years 6

  • The seton may be removed in up to 98% of Crohn's patients at a median of 33 weeks when used with optimal medical therapy 7

Critical Decision Points for Seton Removal

Signs Indicating Readiness for Removal

  • Cessation of purulent drainage is the primary clinical indicator, typically occurring at 18-30 days depending on wound management technique 3

  • Resolution of perianal inflammation and absence of active proctitis on examination 5

  • Completion of anti-TNF induction therapy in Crohn's patients (minimum 4-6 weeks) 5

Risks of Premature Removal

  • Removing the seton too early carries a high risk of recurrent perianal abscess formation, particularly if removed before inflammation has adequately resolved 5

  • In Crohn's disease, early removal before completing anti-TNF induction resulted in a 15% abscess recurrence rate 5

Risks of Prolonged Placement

  • Leaving the seton in place too long may result in epithelialization of the fistula tract, potentially preventing spontaneous closure 5

  • However, long-term seton drainage alone (without definitive closure) was associated with the highest reintervention rate (67%) compared to anti-TNF therapy (40%) or surgical closure (21%) in the PISA trial 6

Algorithm for Seton Management Duration

For Simple Cryptoglandular Fistulas

  1. Insert loose draining seton at initial drainage 8, 7
  2. Monitor for cessation of purulent drainage (typically 2-4 weeks) 3
  3. Remove seton at 6-12 weeks if drainage has resolved and no signs of active inflammation 1
  4. Consider leaving indefinitely if patient prefers this over repeat surgery, as setons can remain in place safely long-term 4

For Crohn's Disease-Associated Fistulas

  1. Place loose draining seton at initial presentation 8, 7
  2. Initiate anti-TNF therapy (infliximab or adalimumab) with concomitant immunomodulator 6
  3. Complete anti-TNF induction phase (minimum 4-6 weeks) before considering seton removal 5
  4. Confirm resolution of proctitis via proctosigmoidoscopy 5
  5. Remove seton at 6-12 weeks if above criteria met 5, 1
  6. For optimal outcomes, proceed to surgical closure within 52 weeks of combined seton/anti-TNF therapy 6

Common Pitfalls to Avoid

  • Never remove a seton before completing anti-TNF induction in Crohn's patients, as this significantly increases abscess recurrence risk 5

  • Do not rely on long-term seton drainage alone as definitive treatment in Crohn's disease, as this approach has the highest reintervention rate and should be combined with medical therapy and/or surgical closure 6

  • Avoid probing for fistulas during acute abscess drainage, as this creates iatrogenic complications; place seton only if obvious fistula is present 8

  • Do not use cutting setons in any context, as they result in keyhole deformity and fecal incontinence rates as high as 57% 5

References

Research

Routine use of setons for the treatment of anal fistulae.

Singapore medical journal, 2002

Guideline

ecco-escp consensus on surgery for crohn's disease.

Journal of Crohn's and Colitis, 2018

Guideline

Seton Insertion for Anal Fistula

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

anorectal emergencies: wses-aast guidelines.

World Journal of Emergency Surgery, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.